MedPath

Clinical Study of Laghvashan Langhan-Pachan With Shunthi Churna In Amlapitta

Phase 2
Not yet recruiting
Conditions
Gastro-esophageal reflux disease without esophagitis,
Registration Number
CTRI/2020/11/028940
Lead Sponsor
Dhanshri Kumbhar
Brief Summary

This study is a randomized control trial of efficacy of Laghvashan Langhan-Pachan with Shunthi Churna in Amlapitta with respect to Ashtang Hridayokta Ama Chikitsa Siddhant. Period of study is 7 days and follow up and assessment of therapy on 8th day. This study is conducted as a compulsory part of PG course at single centre.  Primary outcome of this study is the relief found in signs and symptoms of Amlapitta due to Amapachan. The secondary outcome is to study the process and duration of Laghvashan Langhan-Pachan in Saam disease.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Patients fulfilling the diagnostic criteria of Amlapitta that is with 19 grades out of 37 grades of symptoms will be diagnosed as Amlapitta.

Exclusion Criteria

Patients suffering from other systemic diseases like Parinamshool, Food poisoning, Hypertension, Diabetes, Mental disorders Patients who are steroid/any other dependent Pregnant and lactating woman.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To study the relief found in signs and symptoms of Amlapitta due to Amapachan7days
Secondary Outcome Measures
NameTimeMethod
To study the process and duration of Laghvashan Langhan-Pachan in Saam disease7days

Trial Locations

Locations (1)

Government Ayurveda Hospital

🇮🇳

Nanded, MAHARASHTRA, India

Government Ayurveda Hospital
🇮🇳Nanded, MAHARASHTRA, India
Vd Chhaya D Manjarmkar
Principal investigator
7741813888
kdhanshri96@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.